View ValuationFujian Green Pine 향후 성장Future 기준 점검 1/6Fujian Green Pine (는) 각각 연간 15.3% 및 12.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 14.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.6% 로 예상됩니다.핵심 정보15.3%이익 성장률14.44%EPS 성장률Chemicals 이익 성장28.8%매출 성장률12.5%향후 자기자본이익률11.63%애널리스트 커버리지Low마지막 업데이트16 Jun 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Jun 30Fujian Green Pine Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Fujian Green Pine Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026공고 • Jun 11Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 45 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 45 million worth of its shares. The shares will be repurchased at no more than CNY 10 per share. The purpose of the program is to cancel and reduce registered capital. The program will be funded from company's own funds. The program is subject to the shareholders’ approval. The plan will be valid for 12 months from the company's shareholders’ approval Date.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.16, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.53 per share.Buy Or Sell Opportunity • May 27Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to CN¥8.04. The fair value is estimated to be CN¥10.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 29% in the next 2 years.Board Change • May 20High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. VP & Director Yuecong Lin is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong China공고 • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026공고 • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026공고 • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025공고 • Jul 02Fujian Green Pine Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Fujian Green Pine Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025, at 15:30 China Standard Time.공고 • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025공고 • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.004 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.05 (up from CN¥0.004 loss in 3Q 2023). Revenue: CN¥528.5m (up 2.2% from 3Q 2023). Net income: CN¥25.1m (up CN¥27.2m from 3Q 2023). Profit margin: 4.7% (up from net loss in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Sep 30Now 31% overvalued after recent price riseOver the last 90 days, the stock has risen 30% to CN¥4.65. The fair value is estimated to be CN¥3.54, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in a year. Earnings are forecast to grow by 165,591% in the next year.공고 • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024Fujian Green Pine Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.026 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.026 (up from CN¥0.026 loss in 2Q 2023). Revenue: CN¥477.9m (down 9.3% from 2Q 2023). Net income: CN¥12.9m (up CN¥26.5m from 2Q 2023). Profit margin: 2.7% (up from net loss in 2Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Board Change • Jul 22High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Chairman & President Zhanhua Fan is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • Jun 29Fujian Green Pine Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Fujian Green Pine Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong ChinaNew Risk • Apr 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.공고 • Mar 30Fujian Green Pine Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024New Risk • Feb 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.공고 • Feb 20Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 100 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at no more than CNY 6 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives. If the company fails to use the repurchased shares for the said purpose within 36 months of completion of the program, the unused shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.공고 • Dec 30Fujian Green Pine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.96 loss in 3Q 2022)Third quarter 2023 results: CN¥0.004 loss per share (improved from CN¥0.96 loss in 3Q 2022). Revenue: CN¥517.1m (down 29% from 3Q 2022). Net loss: CN¥2.18m (loss narrowed 100% from 3Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.19 loss in 2Q 2022)Second quarter 2023 results: CN¥0.026 loss per share (improved from CN¥0.19 loss in 2Q 2022). Revenue: CN¥526.9m (down 28% from 2Q 2022). Net loss: CN¥13.6m (loss narrowed 86% from 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.공고 • Aug 12Fujian Green Pine Co., Ltd. Announces Board AppointmentsFujian Green Pine Co., Ltd. held its 1st Extraordinary General Meeting of 2023 on 10 August 2023, approved the appointment of Lin Shida, Lin Yuecong as non-independent directors. Dong Hao, Tang Qingquan, Qian Xiaoming as independent directors, Ma Liu, Liang Yuzhan as non-employee supervisors.Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.12 loss in 1Q 2022)First quarter 2023 results: CN¥0.093 loss per share (improved from CN¥0.12 loss in 1Q 2022). Revenue: CN¥397.1m (down 42% from 1Q 2022). Net loss: CN¥47.9m (loss narrowed 22% from 1Q 2022). Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Danglun Luo was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.96 loss per share (vs CN¥0.12 loss in 3Q 2021)Third quarter 2022 results: CN¥0.96 loss per share (further deteriorated from CN¥0.12 loss in 3Q 2021). Revenue: CN¥726.2m (down 3.7% from 3Q 2021). Net loss: CN¥498.6m (loss widened CN¥436.6m from 3Q 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.17 profit in 2Q 2021)Second quarter 2022 results: CN¥0.19 loss per share (down from CN¥0.17 profit in 2Q 2021). Revenue: CN¥728.8m (down 31% from 2Q 2021). Net loss: CN¥97.3m (down 209% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 40% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 28Full year 2021 earnings released: CN¥1.77 loss per share (vs CN¥0.89 profit in FY 2020)Full year 2021 results: CN¥1.77 loss per share (down from CN¥0.89 profit in FY 2020). Revenue: CN¥3.69b (down 4.4% from FY 2020). Net loss: CN¥911.7m (down 298% from profit in FY 2020). Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥8.35, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.51 per share.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.31, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.Reported Earnings • Oct 28Third quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.26 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥754.2m (down 21% from 3Q 2020). Net loss: CN¥62.0m (down 147% from profit in 3Q 2020).Valuation Update With 7 Day Price Move • Oct 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.33, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 46% over the past year.Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.06b (down 2.8% from 2Q 2020). Net income: CN¥89.5m (down 37% from 2Q 2020). Profit margin: 8.5% (down from 13% in 2Q 2020). The decrease in margin was primarily driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥16.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 30% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.85 per share.Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.96 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥3.86b (up 33% from FY 2019). Net income: CN¥460.8m (up 1.7% from FY 2019). Profit margin: 12% (down from 16% in FY 2019). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Jan 29New 90-day low: CN¥17.52The company is down 22% from its price of CN¥22.36 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥127 per share.Is New 90 Day High Low • Jan 11New 90-day low: CN¥17.60The company is down 25% from its price of CN¥23.39 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥126 per share.Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.36, the stock is trading at a trailing P/E ratio of 19.9x, down from the previous P/E ratio of 23.7x. This compares to an average P/E of 34x in the Chemicals industry in China.Is New 90 Day High Low • Dec 12New 90-day low: CN¥20.45The company is down 3.0% from its price of CN¥21.07 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥128 per share.Valuation Update With 7 Day Price Move • Nov 21Market bids up stock over the past weekAfter last week's 15% share price gain to CN¥25.00, the stock is trading at a trailing P/E ratio of 27.2x, up from the previous P/E ratio of 23.6x. This compares to an average P/E of 40x in the Chemicals industry in China.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥475.6m, up 1.6% from the prior year. Total revenue was CN¥3.74b over the last 12 months, up 56% from the prior year.Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 17% share price decline to CN¥22.35, the stock is trading at a trailing P/E ratio of 25.3x, down from the previous P/E ratio of 30.6x. This compares to an average P/E of 40x in the Chemicals industry in China.Is New 90 Day High Low • Oct 14New 90-day high: CN¥27.00The company is up 20% from its price of CN¥22.51 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥178 per share.이익 및 매출 성장 예측XSEC:300132 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20283,220258N/A-598112/31/20272,915220N/A777112/31/20262,556182N/A38813/31/20262,281173238298N/A12/31/20252,219153284337N/A9/30/20252,106134178226N/A6/30/20252,01875251301N/A3/31/20251,97863252297N/A12/31/20241,94055134179N/A9/30/20241,91527140189N/A6/30/20241,9040182222N/A3/31/20241,953-26119158N/A12/31/20231,969-68116157N/A9/30/20232,216-14993136N/A6/30/20232,425-645212272N/A3/31/20232,627-729212273N/A1/1/20232,917-742270341N/A9/30/20223,171-1,687191428N/A6/30/20223,199-1,251-23233N/A3/31/20223,525-1,064-28041N/A1/1/20223,693-912-33244N/A9/30/20213,776222-372-112N/A6/30/20213,9804152349N/A3/31/20214,011468323705N/A12/31/20203,865461468806N/A9/30/20203,7404767041,003N/A6/30/20203,6524628471,051N/A3/31/20203,286455765884N/A12/31/20192,908453N/A676N/A9/30/20192,392468N/A333N/A6/30/20191,909471N/A14N/A3/31/20191,499421N/A-39N/A12/31/20181,422400N/A45N/A9/30/20181,185290N/A168N/A6/30/20181,013200N/A165N/A3/31/2018911144N/A55N/A12/31/201781195N/A-5N/A9/30/201772683N/A-207N/A6/30/201765160N/A-207N/A3/31/201758740N/A-171N/A12/31/201655733N/A75N/A9/30/201655433N/A319N/A6/30/201657417N/A358N/A3/31/201658410N/A345N/A12/31/201558911N/A100N/A9/30/20156474N/A91N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 300132 의 연간 예상 수익 증가율(15.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 300132 의 연간 수익(15.3%)이 CN 시장(26.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 300132 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 300132 의 수익(연간 12.5%)이 CN 시장(연간 16.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 300132 의 수익(연간 12.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 300132의 자본 수익률은 3년 후 11.6%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 01:25종가2026/07/23 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Fujian Green Pine Co., Ltd.는 7명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zhuonan XuChina International Capital Corporation LimitedXiaodong YINCitic Securities Co., Ltd.Hao JiangEverbright Securities Co. Ltd.4명의 분석가 더 보기
공고 • Jun 30Fujian Green Pine Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Fujian Green Pine Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026
공고 • Jun 11Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 45 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 45 million worth of its shares. The shares will be repurchased at no more than CNY 10 per share. The purpose of the program is to cancel and reduce registered capital. The program will be funded from company's own funds. The program is subject to the shareholders’ approval. The plan will be valid for 12 months from the company's shareholders’ approval Date.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.16, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.53 per share.
Buy Or Sell Opportunity • May 27Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to CN¥8.04. The fair value is estimated to be CN¥10.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 29% in the next 2 years.
Board Change • May 20High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. VP & Director Yuecong Lin is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026Fujian Green Pine Co., Ltd., Annual General Meeting, May 27, 2026, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong China
공고 • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
공고 • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
공고 • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
공고 • Jul 02Fujian Green Pine Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Fujian Green Pine Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2025, at 15:30 China Standard Time.
공고 • Mar 31Fujian Green Pine Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
공고 • Dec 31Fujian Green Pine Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 30Third quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.004 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.05 (up from CN¥0.004 loss in 3Q 2023). Revenue: CN¥528.5m (up 2.2% from 3Q 2023). Net income: CN¥25.1m (up CN¥27.2m from 3Q 2023). Profit margin: 4.7% (up from net loss in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Sep 30Now 31% overvalued after recent price riseOver the last 90 days, the stock has risen 30% to CN¥4.65. The fair value is estimated to be CN¥3.54, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in a year. Earnings are forecast to grow by 165,591% in the next year.
공고 • Sep 30Fujian Green Pine Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024Fujian Green Pine Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.026 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.026 (up from CN¥0.026 loss in 2Q 2023). Revenue: CN¥477.9m (down 9.3% from 2Q 2023). Net income: CN¥12.9m (up CN¥26.5m from 2Q 2023). Profit margin: 2.7% (up from net loss in 2Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Board Change • Jul 22High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Chairman & President Zhanhua Fan is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • Jun 29Fujian Green Pine Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Fujian Green Pine Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
공고 • Apr 29Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024Fujian Green Pine Co., Ltd., Annual General Meeting, May 30, 2024, at 15:30 China Standard Time. Location: No. 50, Dongfu North Road, Nantou Town, Zhongshan, Guangdong China
New Risk • Apr 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
공고 • Mar 30Fujian Green Pine Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
New Risk • Feb 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
공고 • Feb 20Fujian Green Pine Co., Ltd. (SZSE:300132) announces an Equity Buyback for CNY 100 million worth of its shares.Fujian Green Pine Co., Ltd. (SZSE:300132) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at no more than CNY 6 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives. If the company fails to use the repurchased shares for the said purpose within 36 months of completion of the program, the unused shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months.
공고 • Dec 30Fujian Green Pine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Fujian Green Pine Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.96 loss in 3Q 2022)Third quarter 2023 results: CN¥0.004 loss per share (improved from CN¥0.96 loss in 3Q 2022). Revenue: CN¥517.1m (down 29% from 3Q 2022). Net loss: CN¥2.18m (loss narrowed 100% from 3Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.19 loss in 2Q 2022)Second quarter 2023 results: CN¥0.026 loss per share (improved from CN¥0.19 loss in 2Q 2022). Revenue: CN¥526.9m (down 28% from 2Q 2022). Net loss: CN¥13.6m (loss narrowed 86% from 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.
공고 • Aug 12Fujian Green Pine Co., Ltd. Announces Board AppointmentsFujian Green Pine Co., Ltd. held its 1st Extraordinary General Meeting of 2023 on 10 August 2023, approved the appointment of Lin Shida, Lin Yuecong as non-independent directors. Dong Hao, Tang Qingquan, Qian Xiaoming as independent directors, Ma Liu, Liang Yuzhan as non-employee supervisors.
Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.093 loss per share (vs CN¥0.12 loss in 1Q 2022)First quarter 2023 results: CN¥0.093 loss per share (improved from CN¥0.12 loss in 1Q 2022). Revenue: CN¥397.1m (down 42% from 1Q 2022). Net loss: CN¥47.9m (loss narrowed 22% from 1Q 2022). Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Danglun Luo was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.96 loss per share (vs CN¥0.12 loss in 3Q 2021)Third quarter 2022 results: CN¥0.96 loss per share (further deteriorated from CN¥0.12 loss in 3Q 2021). Revenue: CN¥726.2m (down 3.7% from 3Q 2021). Net loss: CN¥498.6m (loss widened CN¥436.6m from 3Q 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.17 profit in 2Q 2021)Second quarter 2022 results: CN¥0.19 loss per share (down from CN¥0.17 profit in 2Q 2021). Revenue: CN¥728.8m (down 31% from 2Q 2021). Net loss: CN¥97.3m (down 209% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 40% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 28Full year 2021 earnings released: CN¥1.77 loss per share (vs CN¥0.89 profit in FY 2020)Full year 2021 results: CN¥1.77 loss per share (down from CN¥0.89 profit in FY 2020). Revenue: CN¥3.69b (down 4.4% from FY 2020). Net loss: CN¥911.7m (down 298% from profit in FY 2020). Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥8.35, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.51 per share.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.31, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.
Reported Earnings • Oct 28Third quarter 2021 earnings released: CN¥0.12 loss per share (vs CN¥0.26 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥754.2m (down 21% from 3Q 2020). Net loss: CN¥62.0m (down 147% from profit in 3Q 2020).
Valuation Update With 7 Day Price Move • Oct 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.33, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 46% over the past year.
Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.06b (down 2.8% from 2Q 2020). Net income: CN¥89.5m (down 37% from 2Q 2020). Profit margin: 8.5% (down from 13% in 2Q 2020). The decrease in margin was primarily driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥16.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 30% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.85 per share.
Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.96 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥3.86b (up 33% from FY 2019). Net income: CN¥460.8m (up 1.7% from FY 2019). Profit margin: 12% (down from 16% in FY 2019). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Jan 29New 90-day low: CN¥17.52The company is down 22% from its price of CN¥22.36 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥127 per share.
Is New 90 Day High Low • Jan 11New 90-day low: CN¥17.60The company is down 25% from its price of CN¥23.39 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥126 per share.
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.36, the stock is trading at a trailing P/E ratio of 19.9x, down from the previous P/E ratio of 23.7x. This compares to an average P/E of 34x in the Chemicals industry in China.
Is New 90 Day High Low • Dec 12New 90-day low: CN¥20.45The company is down 3.0% from its price of CN¥21.07 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥128 per share.
Valuation Update With 7 Day Price Move • Nov 21Market bids up stock over the past weekAfter last week's 15% share price gain to CN¥25.00, the stock is trading at a trailing P/E ratio of 27.2x, up from the previous P/E ratio of 23.6x. This compares to an average P/E of 40x in the Chemicals industry in China.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥475.6m, up 1.6% from the prior year. Total revenue was CN¥3.74b over the last 12 months, up 56% from the prior year.
Valuation Update With 7 Day Price Move • Oct 20Market pulls back on stock over the past weekAfter last week's 17% share price decline to CN¥22.35, the stock is trading at a trailing P/E ratio of 25.3x, down from the previous P/E ratio of 30.6x. This compares to an average P/E of 40x in the Chemicals industry in China.
Is New 90 Day High Low • Oct 14New 90-day high: CN¥27.00The company is up 20% from its price of CN¥22.51 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥178 per share.